Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Jana Koth, a postdoc with Profs Roger Patient (WIMM, RDM) and Paul Riley (DPAG), has won the Mending Broken Hearts prize in this years BHF Reflections of Research Competition for her image of a 2 day old zebrafish heart. The cardiomyocytes are labelled green, meromyosin is red (staining stronger in the ventricle) and myosin is blue. The early heart has started to loop.

This is the front view of a developing two day old zebrafish heart. The green cells are heart muscle cells, and the red and blue staining shows components that make up the muscle. The early heart tube has started to loop. It consists of two sections - the large, thin atrium (where blood flows in) and the smaller, thicker ventricle (where blood leaves the heart).
This is the front view of a developing two day old zebrafish heart. The green cells are heart muscle cells, and the red and blue staining shows components that make up the muscle. The early heart tube has started to loop. It consists of two sections - the large, thin atrium (where blood flows in) and the smaller, thicker ventricle (where blood leaves the heart).
Load More

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

New heart disease calculator could save lives by identifying high-risk patients missed by current tools

Collaborative research, led from NDPCHS and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.